Announcements Trials
Browse Landscape

Status

Completed 7Terminated 1

Sponsor Class

INDUSTRY 6OTHER 2

Study Type

Interventional 10Observational 8

Sponsor

Cancer Type

Breast 8Thoracic 2Gynecologic 2Genitourinary 2Gastrointestinal 2Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Breast Neoplasms 2936Neoplasms 174Lung Neoplasms 149Prostatic Neoplasms 116Ovarian Neoplasms 113Colorectal Neoplasms 106Triple Negative Breast Neoplasms 98Colonic Neoplasms 91Neoplasm Metastasis 74Melanoma 66Carcinoma, Non-Small-Cell Lung 64Pancreatic Neoplasms 63Carcinoma, Intraductal, Noninfiltrating 60Stomach Neoplasms 54Head and Neck Neoplasms 47Breast Cancer Female 45Lymphedema 42Uterine Cervical Neoplasms 40Breast Carcinoma In Situ 35Esophageal Neoplasms 34Cardiotoxicity 34Urinary Bladder Neoplasms 33Motor Activity 33Lymphoma 33Endometrial Neoplasms 33Breast Diseases 33Fatigue 30Rectal Neoplasms 28Breast Neoplasms, Male 28Multiple Myeloma 27

Interventions

Anastrozole 2Leuprolide 1Goserelin 1Clodronic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Observational × Patient Compliance × Breast × Clear all
NCT05122377 2026-01-06

RWE About QOL and Compliance of Patients With OFS in China

Fudan University

Completed
562 enrolled
Breast

Breast Neoplasms, Patient Compliance

NCT01332032 2015-06-01

Promoting Breast Cancer Screening in Non-adherent Women

University of Massachusetts, Worcester

Completed
36,348 enrolled
Breast

Breast Neoplasms, Patient Compliance

NCT01198457 2012-09-07

BONA

Bayer

Completed
147 enrolled
BreastGenitourinaryPlasma cell

Breast Neoplasms, Multiple Myeloma, Osteolysis, Patient Compliance, Prostatic Neoplasms

NCT00890903 2012-07-02

Non-Interventional Study With Vinorelbine ORAL in Advanced Non-Small Cell Lung Carcinoma(NSCLC) and Metastatic Breast Cancer (MBC)

Pierre Fabre Pharma GmbH

Completed
62 enrolled
BreastThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Patient Compliance

NCT00936442 2012-02-14

ARTEMIS

AstraZeneca

Completed
104 enrolled
Breast

Breast Neoplasms, Patient Compliance

NCT00555867 2011-12-23

PACT

AstraZeneca

Terminated
4,923 enrolled
Breast

Breast Neoplasms, Patient Compliance

NCT00523315 2011-05-20

APOLLO

AstraZeneca

Completed
862 enrolled
Breast

Breast Neoplasms, Patient Compliance

NCT00878930 2011-01-05

FRAME

AstraZeneca

Completed
500 enrolled
Breast

Breast Neoplasms, Patient Compliance

Data powered by HemOnc (CC BY 4.0) Colophon âš¡